Pfizer names a VC leader in year of reset; Former Axcella CEO moves on after company shutdown

Michael Diem

→ A spokesperson for Pfizer tells Peer Review that Michael Diem has joined the pharma giant as head of venture capital & equity investments. The AstraZeneca and GSK alum had been with Century Therapeutics since 2020 as CBO and then CFO, and he…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks